Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drug resistance genes].

J P Marie1

  • 1Service d'Hématologie, Hôtel-Dieu de Paris.

Presse Medicale (Paris, France : 1983)
|June 13, 1992
PubMed
Summary
This summary is machine-generated.

Multidrug resistance in tumors is often caused by the mdr1 gene, which produces P-glycoprotein (P-gp) that expels chemotherapy drugs. Research is ongoing to develop P-gp modulators to overcome this resistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Audiological phenotyping evaluation in KBG syndrome: Description of a multicenter review.

International journal of pediatric otorhinolaryngology·2023
Same author

Ruptured dural arteriovenous fistula and sinus venous thrombosis following surgical resection of a vestibular schwannoma: Case report and review of the literature.

Neuro-Chirurgie·2022
Same author

[Vocal cord dysfunction in athletes: Interest of rehabilitation to effort].

Revue des maladies respiratoires·2021
Same author

Stapes surgery in osteogenesis imperfecta: retrospective analysis of 18 operated ears.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2021
Same author

Alteration of Swallowing and Ventilation Coordination in Respiratory Diseases in Small Mammals.

Dysphagia·2019
Same author

Treatment of unilateral vocal fold paralysis with ansa cervicalis to recurrent nerve anastomosis in a young adolescent: European case report.

The Journal of laryngology and otology·2018
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Multidrug resistance (MDR) is a significant challenge in cancer chemotherapy.
  • The mdr1 gene and its encoded protein, P-glycoprotein (P-gp), are key players in MDR.
  • P-gp, an ATP-binding cassette (ABC) transporter, actively effluxes various anticancer drugs from tumor cells.

Purpose of the Study:

  • To investigate the role of the mdr1 gene and P-gp in multidrug resistance.
  • To highlight the clinical relevance of P-gp in drug-resistant tumors.
  • To explore potential therapeutic strategies targeting P-gp.

Main Methods:

  • Investigated mdr1 gene expression and P-gp activity.
  • Reviewed clinical trials involving P-gp modulators and chemotherapy.

Related Experiment Videos

  • Examined other potential drug resistance mechanisms.

    • Main Results:

    • Overexpression of the mdr1 gene leading to increased P-gp levels is a primary mechanism of MDR.
    • Clinical trials are evaluating P-gp modulators in combination with chemotherapy for resistant cancers.
    • Other factors like glutathione levels and topoisomerase activity may also contribute to drug resistance.

    Conclusions:

    • The mdr1 gene/P-gp pathway is a critical determinant of clinical drug resistance in cancer.
    • Targeting P-gp offers a promising strategy to enhance chemotherapy efficacy in resistant tumors.
    • Further research into combined resistance mechanisms is warranted.